In the first two months, the export of pharmaceutical products from Xuancheng reached 16.72 million yuan
Recently, there was a busy scene in Mount Huangshan Capsule Co., Ltd., Anhui Province. A batch of gelatin hollow capsules worth 280000 yuan were successfully cleared and will be sent to the US market.
As a leading enterprise in Jingde County's bio pharmaceutical industry, Mount Huangshan Capsules Co., Ltd. has been deeply engaged in the field of hollow capsules for more than 30 years, and is an important manufacturer in the domestic pharmaceutical hollow capsule industry. The company's independently developed innovative products such as hydroxypropyl methylcellulose (HPMC) capsules, enteric coated gelatin capsules, and targeted enteric coated capsules continue to gain global market favor due to their stable quality, precise release technology, and excellent safety performance. Since 2026, the company's export business has maintained a good growth trend, with products exported to multiple countries and regions such as the United States, Saudi Arabia, Egypt, Indonesia, Brazil, and long-term strategic cooperation with Southeast Asian customers.
Since obtaining the AEO certification, the international market recognition of our products has greatly increased. Not only has the clearance efficiency increased by more than 40%, but we have also successfully opened the door to markets such as the United States. ”According to Wei Yaoling, the manager of the company's foreign trade department, under the guidance of customs policies, the DMF filing number of the company's gelatin hollow capsules has been associated with FDA preparations, becoming the designated excipient supplier for multiple domestic pharmaceutical companies exporting foreign drugs.
In response to the high compliance requirements and strict customs clearance time requirements for the export of pharmaceutical products, Xuancheng Customs under Hefei Customs has implemented the facilitation measures of "early declaration, two-step declaration, inspection upon declaration, and release upon qualification", expanding the scope of remote local inspection pilot products to low-risk special items for export. Through remote visual inspection, the overall operation time has been significantly reduced; Optimize the approval process for health quarantine of special items for export, achieve immediate reporting and approval of quarantine approval applications for key scientific research and industrial projects, shorten the approval time, and achieve "zero waiting" for pharmaceutical product clearance.
With the comprehensive support of customs, the company relies on the "DMF+overseas warehouse" model to continuously cultivate the international market. The cross-border e-commerce "9710" export business is steadily advancing, and the export scale and brand influence are synchronously increasing.
In the first two months of this year, the export of pharmaceutical products in Xuancheng City reached 16.72 million yuan, a year-on-year increase of 396.5%. Next, Xuancheng Customs will continue to pay attention to the development needs of the pharmaceutical industry, continuously deepen the docking services between customs and enterprises, continuously optimize the regulatory service model, promote the implementation and effectiveness of various preferential policies for enterprises, fully support pharmaceutical enterprises in the jurisdiction to enhance their international competitive advantages, and help more high-quality medical products in Xuancheng set sail and go global, injecting stronger impetus into the high-quality development of local foreign trade economy. (Zhang Zhichen)